Yazar "Mesbahi, Asghar" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    Innovative nano-shielding for minimizing stray radiation dose in external radiation therapy: A promising approach to enhance patient safety
    (Elsevier B.V., 2024) Rajabpour, Saeed; Almisned, Ghada; Tekin, Hüseyin Ozan; Mesbahi, Asghar
    This study investigates the effectiveness of novel nanocomposite shielding materials in reducing out-of-field radiation doses during radiation therapy, employing Geant4 Monte Carlo (MC) simulations alongside an anthropomorphic female phantom. The research focuses on two radiation modalities: 6 MV beams with and without flattening filters. Utilizing the Geant4 MC code, detailed simulations of a Varian Clinac 2100C/D linear accelerator and an ICRP-145 mesh-type human phantom were conducted to estimate the doses to out-of-field organs from unintended secondary radiation. This involved simulating a comprehensive linac model, including all relevant beam-line components, and assessing the shielding effects of three different nanocomposites doped with metal nanoparticles at various thicknesses. The nanocomposites, comprising Polytetrafluoroethylene (PTFE), with PtO2, IrO2, and Bi2O3 nanoparticles, were evaluated for their potential to reduce patient organ doses from stray photon doses. The results showed that these materials could significantly lower radiation exposure to non-target tissues. © 2024 Elsevier B.V.
  • Küçük Resim
    Öğe
    Radiosensitization with metallic nanoparticles under MeV proton beams: local dose enhancement
    (Springer science and business media deutschland GmbH, 2024) Mansouri, Elham; Almisned, Ghada; Tekin, Hüseyin Ozan; Rajabpour, Saeed; Mesbahi, Asghar
    In addition to specific dosimetric properties of protons, their higher biological effectiveness makes them superior to X-rays and gamma radiation, in radiation therapy. In recent years, enrichment of tumours with metallic nanoparticles as radiosensitizer agents has generated high interest, with several studies attempting to confirm the efficacy of nanoparticles in proton therapy. In the present study Geant4 Monte Carlo (MC) code was used to quantify the increased nanoscopic dose deposition of 50 nm metallic nanoparticles including gold, bismuth, iridium, and gadolinium in water upon exposure to 5, 25, and 50 MeV protons. Dose enhancement factors, radial dose distributions in nano-scale, as well as secondary electron and photon energy spectra were calculated for the studied nanoparticles and proton beams. The obtained results demonstrated that in the presence of metallic nanoparticles an increase in proton energy leads to a decrease in secondary electron and photon production yield. Additionally, an increase in the radial dose enhancement factor from 1.4 to 16 was calculated for the studied nanoparticles when the proton energy was increased from 5 to 50 MeV. It is concluded that the dosimetric advantages of proton beams could be improved significantly in the presence of metallic nanoparticles.